Valuation Eurofins Scientific SE

Stocks

Real-time Euronext Paris 16:15:42 10/09/2026 +03			5-day change	1st Jan Change
71.30 ^EUR	+0.51%		-2.94%	+14.26%

09-08	Eurofins Scientific Downgraded by Morgan Stanley
08-24	Wall Street's Three-Way Stress Test

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	20,893	12,900	11,336	9,273	11,036	12,315	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	11.59%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	14,677	15,681	15,349	15,111
Change	-	-31.96%	-10.79%	-12.62%	19.63%	6.84%	-2.12%	-1.55%
P/E	27.8x	22.2x	45.4x	26.9x	28x	23.7x	18.7x	15.8x
PBR	4.49x	2.7x	2.24x	1.73x	2.56x	2.63x	2.39x	2.21x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.7x	0.7x	0.8x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.62x	1.54x	1.44x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	2.01x	2.07x	1.92x	1.77x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	8.94x	8.96x	8.1x	7.32x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	13.6x	13.9x	12.3x	10.9x
EV / FCF	22.8x	23.2x	29.6x	15.3x	16.7x	18x	16.2x	14.5x
FCF Yield	4.39%	4.3%	3.38%	6.53%	5.97%	5.55%	6.19%	6.89%
Dividend per Share ²	1	1	0.5	0.5	0.72	0.8022	0.908	0.9603
Rate of return	0.92%	1.49%	0.85%	1.01%	1.15%	1.13%	1.28%	1.35%
EPS ²	3.91	3.02	1.3	1.83	2.23	2.999	3.796	4.504
Distribution rate	25.6%	33.1%	38.5%	27.3%	32.3%	26.7%	23.9%	21.3%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,583	7,998	8,529
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,750	1,895	2,064
EBIT ¹	1,473	1,037	842	1,017	1,079	1,129	1,250	1,387
Net income ¹	783	606	310	406	475	530.9	659.7	817.4
Net Debt ¹	2,239	2,839	2,705	2,996	3,641	3,366	3,034	2,796
Reference price ²	108.80	67.06	58.98	49.31	62.40	70.94	70.94	70.94
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	173,599	-	-
Announcement Date	2/22/22 A	3/1/23 A	2/27/24 A	1/30/25 A	1/29/26 A	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EUROFINS SCIENTIFIC SE	23.65x	2.07x	8.96x	1.13%	14.31B
LONZA GROUP AG	31.44x	5.66x	16.96x	1.03%	46.38B
REVOLUTION MEDICINES, INC.	-21.25x	245.77x	-22.82x	-.--%	44.51B
IQVIA HOLDINGS INC.	33.09x	3.22x	13.91x	-.--%	42.3B
BEONE MEDICINES AG	45.98x	5.31x	29.05x	-.--%	39.91B
CELLTRION, INC.	27.78x	8.36x	21.2x	0.41%	32.79B
MEDPACE HOLDINGS, INC.	33.34x	5.46x	24.79x	-.--%	16.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.46x	3.94x	15.27x	-.--%	13.29B
ICON PUBLIC LIMITED COMPANY	27.08x	1.8x	11.04x	-.--%	12.31B
Average	30.62x	31.29x	13.15x	0.29%	29.13B
Weighted average by Cap.	26.19x	45.84x	11.77x	0.3%